Radnet Inc

RDNTNASDAQ · USD
69.71USD0.00 (+0.29%)
297

Radnet Inc (RDNT) Covered Calls

Radnet Inc trades in the Diagnostics & Research industry with an IV Rank of 28.97%, low versus the past year. RDNT's highest covered call setup is the $115.00 strike expiring Mar 19, 2027, sorted by theoretical annualized return. It's 60.12% out of the money with 121 days to expiration, a 60.19% return until expiration, and a 181.57% theoretical annualized return. Across the setups shown, annualized returns run from 63.97% to 181.57% at strikes between $75.00 and $120.00, with 30 to 211 days to expiration, as of Nov 18, 2026.

Read more

Running RDNT covered calls helps you generate income from Radnet Inc shares you already own, turning a long stock position into a yield producing asset. A covered call means holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike. Use our scanner to find the best RDNT covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call pairs limited risk with a clear income profile. If RDNT stays below the strike at expiration, you keep the premium and the shares. If it rises above, you deliver the stock at the strike and still pocket the premium. Selling RDNT covered calls works best when implied volatility is elevated, since richer premiums improve the risk reward. Key inputs include strike selection relative to delta, days to expiration, annualized return, and probability of assignment, all of which determine whether a given RDNT covered call is worth writing.

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems for the diagnostic imaging industry, including picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of images in the field of mammography, as well as AI solutions for lung and prostate cancer.

2027-03-19121115.0060.120.052.004323.0060.19181.57-0.07+0.1191.95
2026-12-183080.0011.390.901.35908.0012.64153.82-1.25+0.232470.45
2027-03-19121100.0039.240.603.102878.0040.07120.88-0.84+0.1882.50
2027-06-17211120.0067.080.251.504843.0067.43116.65-0.35+0.0901.25
2027-03-1912195.0032.280.352.952353.0032.7698.83-0.49+0.181132.60
2026-12-183075.004.432.152.80533.007.4290.29-2.99+0.40710.65
2027-06-17211105.0046.200.653.803383.0047.1081.48-0.91+0.1973.15
2027-03-1912190.0025.310.904.001908.0026.5780.14-1.25+0.25103.10
2027-06-17211100.0039.241.653.502983.0041.5371.85-2.30+0.22111.85
2027-03-1912185.0018.352.054.901523.0021.2163.97-2.85+0.32342.85

As of Nov 18, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →

Stock Statistics

  • IndustryDiagnostics & Research
  • SectorHealthcare
  • IV Rank28.97% Low
  • Market cap (M$)5,491
  • 52 weeks high-18.79%
  • 52 weeks low37.17%
  • Analyst recommendationStrong Buy
    1.11
  • Target price$97.00
    39.15% above the current stock price
  • Dividend—
  • Payout ratio—
  • Earnings date2026-11-08
  • P/E—
  • Future P/E71.24
  • EPS (ttm)-0.29
  • EPS growth next 5 years45.61%

As of Nov 20, 2026